Illumina AI Tool for Rare Diseases

Illumina introduced an AI tool aiding in the diagnosis of rare diseases. This innovation enhances genetic analysis for complex conditions. It was highlighted in biotech news updates.

Gene mutation raises disease risk by 50 percent

September 30, 2025 Reported by AI

A new study has identified a specific gene mutation that increases the risk of type 2 diabetes by 50 percent. Led by researchers at the University of California, Berkeley, the findings come from a five-year analysis of 1,000 participants. The discovery highlights potential pathways for early detection and treatment.

Study identifies potential genetic subtypes of autism

Researchers have proposed that autism spectrum disorder may consist of genetically distinct subtypes, based on an analysis of large-scale genetic data. This finding could lead to more personalized approaches to diagnosis and treatment. The study highlights variations in genetic markers among individuals with autism.

Evolution of human intelligence linked to mental illness vulnerability

October 11, 2025 Reported by AI

Researchers have traced genetic variants in the human genome to reveal that advances in cognitive abilities around 500,000 years ago were soon followed by mutations increasing susceptibility to psychiatric disorders. This suggests a trade-off in brain evolution. The study, published in Cerebral Cortex, analyzed 33,000 genetic variants to build an evolutionary timeline of brain-related traits.

CRISPR Tool Targets Neuron Gene Repair

September 15, 2025 Reported by AI

Stanford researchers have created a CRISPR-based technology to target RNA in neurons, enabling repair processes for genetic diseases. The method addresses key challenges in Cas9 delivery and DNA repair. It reveals unique genome editing rules in neurons, paving the way for targeted therapies.